Orion stock holds high €78 range as earnings drive 2026

Orion stock trades in the high €78 range as 2026 earnings and guidance support the valuation, with shares at €78.45 on August 19, 2026 and year-to-date performance of 25.87 percent.

Orion (ISIN FI0009014377) stock traded at €78.45 on August 19, 2026, after a recent quote snapshot also showed €78.95 and a year-to-date gain of 23.46 percent. The Finnish pharmaceuticals group is being priced against its latest 2026 quarter, where revenue, profit and earnings per share all moved higher from a year earlier.

Earnings stay in view

Recent reporting on the latest quarter points to continued growth in core prescription medicines and specialty products, with management emphasizing cost control and margin protection. The same coverage says the company is still benefiting from demand in neurology and oncology, two areas that support the current earnings base.

The comparison matters. The reported 2026 quarter showed higher revenue than the same period a year earlier, net income also increased year over year, and earnings per share came in above the prior-year figure.

Valuation and momentum

Market data from August 19, 2026 places Orion at €78.45, while a separate same-day quote overview put the shares at €78.95 with a 0.70 percent daily rise. The stock has also been shown with a flat five-day change and a year-to-date advance between 23.46 percent and 25.87 percent, depending on the snapshot.

That gap between a flat short-term move and a strong year-to-date gain suggests investors are still anchoring the name to the latest earnings trend rather than to one trading session alone.

Prescription medicine mix

Orion's prescription medicines portfolio remains the core business, with neurology and oncology contributing to the company's revenue mix. Those therapy areas also help explain why the latest quarter mattered more than a single daily price print.

Recent close

Orion shares were last shown at €78.45 as of August 19, 2026, with another snapshot at €78.95. The euro-denominated range leaves the stock trading well above the start of the year and keeps the 2026 earnings path in focus.

Fact box

Company: Orion

ISIN: FI0009014377

Ticker: OFK

Exchange: Home-market listing in the eurozone

Price (as of August 19, 2026, 4:02 p.m. ET): €78.45

Sector / Industry: Pharmaceuticals and healthcare

Index membership: regional European healthcare indexes

More on Orion stock

Orion's prescription medicines business includes treatments across neurology, oncology and specialty areas.